These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20401587)

  • 1. Use of DNA arrays to study transcriptional responses to antimycobacterial compounds.
    Waddell SJ; Butcher PD
    Methods Mol Biol; 2010; 642():75-91. PubMed ID: 20401587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic approach to identifying the putative target of and mechanisms of resistance to mefloquine in mycobacteria.
    Danelishvili L; Wu M; Young LS; Bermudez LE
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3707-14. PubMed ID: 16127044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the mode of action of bioactive compounds by microfluidic transcriptional profiling in mycobacteria.
    Murima P; de Sessions PF; Lim V; Naim AN; Bifani P; Boshoff HI; Sambandamurthy VK; Dick T; Hibberd ML; Schreiber M; Rao SP
    PLoS One; 2013; 8(7):e69191. PubMed ID: 23935951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation of multi-drug tolerance and antibiotic-induced responses by the histone-like protein Lsr2 in M. tuberculosis.
    Colangeli R; Helb D; Vilchèze C; Hazbón MH; Lee CG; Safi H; Sayers B; Sardone I; Jones MB; Fleischmann RD; Peterson SN; Jacobs WR; Alland D
    PLoS Pathog; 2007 Jun; 3(6):e87. PubMed ID: 17590082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds.
    Waddell SJ; Stabler RA; Laing K; Kremer L; Reynolds RC; Besra GS
    Tuberculosis (Edinb); 2004; 84(3-4):263-74. PubMed ID: 15207496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substituted xanthones as antimycobacterial agents, Part 2: Antimycobacterial activity.
    Pickert M; Schaper KJ; Frahm AW
    Arch Pharm (Weinheim); 1998 May; 331(5):193-7. PubMed ID: 9691249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of a novel antimycobacterial compound, N-octanesulfonylacetamide, and its effects on lipid and mycolic acid synthesis.
    Parrish NM; Houston T; Jones PB; Townsend C; Dick JD
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1143-50. PubMed ID: 11257028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide deformylase inhibitors as potent antimycobacterial agents.
    Teo JW; Thayalan P; Beer D; Yap AS; Nanjundappa M; Ngew X; Duraiswamy J; Liung S; Dartois V; Schreiber M; Hasan S; Cynamon M; Ryder NS; Yang X; Weidmann B; Bracken K; Dick T; Mukherjee K
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3665-73. PubMed ID: 16966397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of silver-carrying photocatalyst "Hikari-Gintech" on mycobacterial growth in vitro.
    Matsui Y; Otomo K; Ishida S; Yanagihara K; Kawanobe Y; Kida S; Taruoka E; Sugawara I
    Microbiol Immunol; 2004; 48(7):489-95. PubMed ID: 15272193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimycobacterial activity of cerulenin and its effects on lipid biosynthesis.
    Parrish NM; Kuhajda FP; Heine HS; Bishai WR; Dick JD
    J Antimicrob Chemother; 1999 Feb; 43(2):219-26. PubMed ID: 11252327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
    Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM
    Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity of long-chain fatty alcohols against mycobacteria.
    Mukherjee K; Tribedi P; Mukhopadhyay B; Sil AK
    FEMS Microbiol Lett; 2013 Jan; 338(2):177-83. PubMed ID: 23136919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannich Ketones as Possible Antimycobacterial Agents.
    Lutz Z; Orbán K; Bóna Á; Márk L; Maász G; Prókai L; Seress L; Lóránd T
    Arch Pharm (Weinheim); 2017 Sep; 350(9):. PubMed ID: 28752666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene chip array for differentiation of mycobacterial species and detection of drug resistance.
    Shi XC; Liu XQ; Xie XL; Xu YC; Zhao ZX
    Chin Med J (Engl); 2012 Sep; 125(18):3292-7. PubMed ID: 22964326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mycobacterial tests].
    Takashima T; Higuchi T
    Kekkaku; 2008 Jan; 83(1):43-59. PubMed ID: 18283915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient point mutagenesis in mycobacteria using single-stranded DNA recombineering: characterization of antimycobacterial drug targets.
    van Kessel JC; Hatfull GF
    Mol Microbiol; 2008 Mar; 67(5):1094-107. PubMed ID: 18221264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foundations of antibiotic resistance in bacterial physiology: the mycobacterial paradigm.
    Nguyen L; Thompson CJ
    Trends Microbiol; 2006 Jul; 14(7):304-12. PubMed ID: 16759863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.